Skip to main content
. 2023 Jul 7;8:262. doi: 10.1038/s41392-023-01469-6

Fig. 3.

Fig. 3

Schematic representation of cardiotoxicity screening before, during, and after cancer therapy. Specific screening criteria based on the types the therapies are proposed. CMR, cardiac MRI; and HER, human epidermal growth factor receptor